ArticleTranslational lung cancer research2026
Cadonilimab induction and consolidation for unresectable stage III non-small cell lung cancer patients receiving concurrent chemoradiation: safety run-in results of a prospective, phase II trial.
Jianjiao Ni et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.